Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus; HIV”

1,614 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,614 results

Not applicableUnknownNCT05727033
What this trial is testing

Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections

Who this might be right for
Chlamydia InfectionsGonorrheaSyphilis Infection+3 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 1,200
Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Post-approval studies (Phase 4)UnknownNCT05075044
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

Who this might be right for
HIV InfectionsCOVID-19
China National Biotec Group Company Limited 400
Large-scale testing (Phase 3)Active Not RecruitingNCT05630755
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 514
Testing effectiveness (Phase 2)Study completedNCT00972699
What this trial is testing

Mentor Mothers: A Sustainable Family Intervention in South African Townships

Who this might be right for
Human Immunodeficiency VirusAcquired Immune Deficiency SyndromeTuberculosis
University of California, Los Angeles 1,200
Early research (Phase 1)Study completedNCT02185300
What this trial is testing

Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 15
Testing effectiveness (Phase 2)UnknownNCT02648516
What this trial is testing

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients

Who this might be right for
Human Immunodeficiency VirusDisorder of Immune Reconstitution
Beijing 302 Hospital 20
Not applicableStudy completedNCT02128087
What this trial is testing

Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders

Who this might be right for
Human Immunodeficiency Virus
RAND 330
Not applicableStudy completedNCT04033887
What this trial is testing

Evaluation Study of RDTs Detecting Antibodies Against HCV

Who this might be right for
Hepatitis C
Foundation for Innovative New Diagnostics, Switzerland 1,710
Early research (Phase 1)Study completedNCT00879047
What this trial is testing

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Who this might be right for
HIV InfectionsHepatitis C
University of California, San Francisco 30
Not applicableStudy completedNCT01662336
What this trial is testing

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Who this might be right for
Human Immunodeficiency Virus Infection
AbbVie (prior sponsor, Abbott) 173
Large-scale testing (Phase 3)Ended earlyNCT01731691
What this trial is testing

Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease

Who this might be right for
HIV Disease
Institute for Human Genetics and Biochemistry 12
Not applicableStudy completedNCT03300908
What this trial is testing

Contextualizing & Responding to HIV Risk Behaviors

Who this might be right for
Human Immunodeficiency Virus
Columbia University 32
Not applicableStudy completedNCT03666247
What this trial is testing

Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM)

Who this might be right for
Human Immunodeficiency Virus
Emory University 1,229
Testing effectiveness (Phase 2)Study completedNCT00643643
What this trial is testing

Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Who this might be right for
HIV Infections
ViiV Healthcare 41
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Not applicableStudy completedNCT06915779
What this trial is testing

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Who this might be right for
Cervical CancerHuman Papillomavirus InfectionHuman Immunodeficiency Virus+2 more
University of British Columbia 241
Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Not applicableStudy completedNCT00955591
What this trial is testing

Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men

Who this might be right for
Anal CancerNonneoplastic ConditionPrecancerous Condition
Jonsson Comprehensive Cancer Center 48
Large-scale testing (Phase 3)Study completedNCT01032408
What this trial is testing

Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection

Who this might be right for
H1N1 Influenza VirusHuman Immunodeficiency Virus Type 1 (HIV-1) Infection
Chiltern Pesquisa Clinica Ltda 154
Load More Results